Global Human Embryonic Stem Cell Market Analysis 2024-2034:
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The
Stay updated with breaking news from Stem Cell Therapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The
Exa-cel earned its second FDA approval. The one-time therapy, which has a list price of $2.2 million in the United States, should be available for patients early this year.
Regenerative medicine has been growing in orthopedics, and there's one important element that can push it forward in the field.
The deaths are unrelated to the investigational allogeneic stem cell–derived product VX-880, the company says.
The L V Prasad Eye Institute (LVPEI) has secured a 20-year patent for an innovative cell therapy designed to mend damaged corneas caused by various corneal diseases. This article highlights the potential of the therapy to revolutionize corneal pathology treatment.